Centene Shares Plummet After Withdrawal of 2025 Guidance Amid Rising Medical Costs

jueves, 3 de julio de 2025, 5:52 am ET1 min de lectura
CNC--
CVS--
HUM--
UNH--

Centene withdrew its 2025 financial guidance, citing earnings that will fall short of expectations. This move, combined with UnitedHealth's withdrawal of guidance and replacement of CEO, has added to investor concerns about the insurance sector. Higher-than-expected medical costs have affected Humana and CVS Health's Aetna last year, leading to new CEOs at both companies.

Centene Shares Plummet After Withdrawal of 2025 Guidance Amid Rising Medical Costs

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios